340binformed.org

Research Illustrates Critical Role 340B Plays for Rural Hospitals and Patients

Print ArticleSept. 7, 2023— Recent peer-reviewed research illustrates one of the many ways 340B savings bolster the nation’s rural hospitals and the communities and patients who rely on them for care. The findings help enrich a deep and growing evidence base for the vital role 340B is playing in American health care. Researchers from the University […]

New Research Finds No Evidence 340B Discounts Affect Prescribing

Print ArticleJune 15, 2023— Newly published research illustrates that while 340B hospitals tend to treat patients who are sicker and in greater need of care, they do not prescribe more expensive drugs than non-340B hospitals after those differences are taken into account. The latest evidence appears in the peer-reviewed Journal of the American Medical Association […]

UPDATED: Drugmakers Cutting 340B Discounts Reported Record Revenues in 2021

January 13, 2023– Note: This story is updated to include information for Biogen, which announced 340B restrictions in December 2022. The 19 drug companies that have imposed restrictions on safety-net hospital access to 340B drug pricing program … [Read More...]

For Patients, Symptoms of Drugmaker 340B Restrictions Include Shortness of Breath, Hospitalization

Dec. 23, 2022— The examples of worsened health outcomes for patients from drug company restrictions on 340B pricing to safety-net hospitals continue to mount. At Riverside Regional Medical Center in Virginia, one discharged patient with diabetes … [Read More...]

End to Medicare 340B Payment Cuts in Sight

Dec. 9, 2022— On Jan. 1, hospitals participating in the 340B drug pricing program will start off the new year with something they have not had since 2017 – full Medicare payment rates for 340B-purchased drugs. While those hospitals say the end to the … [Read More...]

340B Helps Replace Emergency Care with Coordinated Care

Nov. 22, 2022— No patient should be showing up in the emergency department as many as 20 times per year because of their chronic health conditions. But nearly a decade ago, the staff at Hennepin Healthcare in Minneapolis were noticing this happening … [Read More...]

Henry Waxman Reflects on 340B’s 30-Year Legacy

Nov. 10, 2022— It is safe to say the 340B drug pricing program would not be what it is today without former Congressman Henry Waxman. In fact, 340B might not even exist. As chairman of the key congressional committee with jurisdiction over health … [Read More...]

30 Years of Care: A Happy, Healthy Anniversary for 340B!

Nov. 4, 2022— Today marks the 30th anniversary of the enactment of the 340B drug pricing program. With his signature on Nov. 4, 1992, President George H.W. Bush completed a bipartisan effort in Congress to protect the health care safety net and boost … [Read More...]

Help From 340B After a Rare Diagnosis and an Unaffordable Bill